GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Addex Therapeutics Ltd (XSWX:ADXN) » Definitions » Shiller PE Ratio

Addex Therapeutics (XSWX:ADXN) Shiller PE Ratio : (As of Jun. 05, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Addex Therapeutics Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Addex Therapeutics Shiller PE Ratio Historical Data

The historical data trend for Addex Therapeutics's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Addex Therapeutics Shiller PE Ratio Chart

Addex Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Addex Therapeutics Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Addex Therapeutics's Shiller PE Ratio

For the Biotechnology subindustry, Addex Therapeutics's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Addex Therapeutics's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Addex Therapeutics's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Addex Therapeutics's Shiller PE Ratio falls into.



Addex Therapeutics Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Addex Therapeutics's E10 for the quarter that ended in Dec. 2023 is calculated as:

For example, Addex Therapeutics's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.03/106.4612*106.4612
=-0.030

Current CPI (Dec. 2023) = 106.4612.

Addex Therapeutics Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200906 -3.420 101.608 -3.583
200912 -4.020 101.610 -4.212
201006 -3.010 102.102 -3.139
201012 -2.680 102.138 -2.793
201106 -2.070 102.678 -2.146
201112 -2.120 101.408 -2.226
201206 -1.930 101.596 -2.022
201212 -1.430 100.968 -1.508
201306 -1.610 101.466 -1.689
201312 0.010 101.036 0.011
201406 -0.100 101.517 -0.105
201412 -0.080 100.704 -0.085
201506 -0.260 100.464 -0.276
201512 -0.130 99.386 -0.139
201606 -0.130 100.088 -0.138
201612 -0.150 99.380 -0.161
201706 -0.140 100.285 -0.149
201712 -0.110 100.213 -0.117
201806 0.100 101.435 0.105
201812 -0.190 100.906 -0.200
201903 -0.120 101.571 -0.126
201906 -0.170 102.044 -0.177
201909 -0.140 101.396 -0.147
201912 -0.140 101.063 -0.147
202003 -0.160 101.048 -0.169
202006 -0.120 100.743 -0.127
202009 -0.120 100.585 -0.127
202012 -0.080 100.241 -0.085
202103 -0.080 100.800 -0.084
202106 -0.140 101.352 -0.147
202109 -0.110 101.533 -0.115
202112 -0.130 101.776 -0.136
202203 -0.150 103.205 -0.155
202206 -0.190 104.783 -0.193
202209 -0.090 104.835 -0.091
202212 -0.040 104.666 -0.041
202303 -0.040 106.245 -0.040
202306 -0.040 106.576 -0.040
202309 -0.030 106.570 -0.030
202312 -0.030 106.461 -0.030

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Addex Therapeutics  (XSWX:ADXN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Addex Therapeutics Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Addex Therapeutics's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Addex Therapeutics (XSWX:ADXN) Business Description

Traded in Other Exchanges
Address
Chemin des Aulx 12, Plan-les-Ouates, P.O. Box 68, Geneva, CHE, 1202
Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Addex Therapeutics (XSWX:ADXN) Headlines

From GuruFocus

Enamine Extend Collaboration With Prominent Swiss Biotech

By Business Wire Business Wire 02-24-2021